Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Utility of the Radiotracer "FET"in PET Imaging of Recurrent Glioblastoma Multiforme (GBM): Monitoring Early Response to Antiangiogenic Therapy

NCT01756352 is registered in ClinicalTrials.gov with Marcelo F. Di Carli, MD, FACC as lead sponsor.

NCT NCT01756352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Utility of the Radiotracer "FET"in PET Imaging of Recurrent Glioblastoma Multiforme (GBM): Monitoring Early Response to Antiangiogenic Therapy
Lead sponsor
Marcelo F. Di Carli, MD, FACC
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
September 13, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gbm, glioblastoma multiforme